Home » Archive

Articles tagged with: Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development

Departments, Meetings »

[1 Jan 2020 | Comments Off on ASA to Cosponsor AI in Clinical Drug Development Symposium in May | ]

The Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development aims to advance the use of artificial intelligence (AI) in drug development and deployment.